Cargando…

Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE)

Hinokitiol is a natural tropolone derivative that is present in the heartwood of cupressaceous plants, and has been extensively investigated for its anti-inflammatory, antioxidant, and antitumor properties in the context of various diseases. To date, the effects of hinokitiol on endometrial cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hsin-Yuan, Cheng, Wen-Pin, Chiang, Yi-Fen, Hong, Yong-Han, Ali, Mohamed, Huang, Tsui-Chin, Wang, Kai-Lee, Shieh, Tzong-Ming, Chang, Hsin-Yi, Hsia, Shih-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348875/
https://www.ncbi.nlm.nih.gov/pubmed/34361036
http://dx.doi.org/10.3390/ijms22158268
_version_ 1783735447485153280
author Chen, Hsin-Yuan
Cheng, Wen-Pin
Chiang, Yi-Fen
Hong, Yong-Han
Ali, Mohamed
Huang, Tsui-Chin
Wang, Kai-Lee
Shieh, Tzong-Ming
Chang, Hsin-Yi
Hsia, Shih-Min
author_facet Chen, Hsin-Yuan
Cheng, Wen-Pin
Chiang, Yi-Fen
Hong, Yong-Han
Ali, Mohamed
Huang, Tsui-Chin
Wang, Kai-Lee
Shieh, Tzong-Ming
Chang, Hsin-Yi
Hsia, Shih-Min
author_sort Chen, Hsin-Yuan
collection PubMed
description Hinokitiol is a natural tropolone derivative that is present in the heartwood of cupressaceous plants, and has been extensively investigated for its anti-inflammatory, antioxidant, and antitumor properties in the context of various diseases. To date, the effects of hinokitiol on endometrial cancer (EC) has not been explored. The purpose of our study was to investigate the anti-proliferative effects of hinokitiol on EC cells. Cell viability was determined with an MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, and the quantification of apoptosis and reactive oxygen species (ROSs) was performed by using flow cytometry, while protein expression was measured with the Western blotting technique. Hinokitiol significantly suppressed cell proliferation through the inhibition of the expression of cell-cycle mediators, such as cyclin D1 and cyclin-dependent kinase 4 (CDK4), as well as the induction of the tumor suppressor protein p53. In addition, hinokitiol increased the number of apoptotic cells and increased the protein expression of cleaved-poly-ADP-ribose polymerase (PARP) and active cleaved-caspase-3, as well as the ratio of Bcl-2-associated X protein (Bax) to B-cell lymphoma 2 (Bcl-2). Interestingly, except for KLE cells, hinokitiol induced autophagy by promoting the accumulation of the microtubule-associated protein light chain 3B (LC3B) and reducing the sequestosome-1 (p62/SQSTM1) protein level. Furthermore, hinokitiol triggered ROS production and upregulated the phosphorylation of extracellular-signal-regulated kinase (p-ERK1/2) in EC cells. These results demonstrate that hinokitiol has potential anti-proliferative and pro-apoptotic benefits in the treatment of endometrial cancer cell lines (Ishikawa, HEC-1A, and KLE).
format Online
Article
Text
id pubmed-8348875
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83488752021-08-08 Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE) Chen, Hsin-Yuan Cheng, Wen-Pin Chiang, Yi-Fen Hong, Yong-Han Ali, Mohamed Huang, Tsui-Chin Wang, Kai-Lee Shieh, Tzong-Ming Chang, Hsin-Yi Hsia, Shih-Min Int J Mol Sci Article Hinokitiol is a natural tropolone derivative that is present in the heartwood of cupressaceous plants, and has been extensively investigated for its anti-inflammatory, antioxidant, and antitumor properties in the context of various diseases. To date, the effects of hinokitiol on endometrial cancer (EC) has not been explored. The purpose of our study was to investigate the anti-proliferative effects of hinokitiol on EC cells. Cell viability was determined with an MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, and the quantification of apoptosis and reactive oxygen species (ROSs) was performed by using flow cytometry, while protein expression was measured with the Western blotting technique. Hinokitiol significantly suppressed cell proliferation through the inhibition of the expression of cell-cycle mediators, such as cyclin D1 and cyclin-dependent kinase 4 (CDK4), as well as the induction of the tumor suppressor protein p53. In addition, hinokitiol increased the number of apoptotic cells and increased the protein expression of cleaved-poly-ADP-ribose polymerase (PARP) and active cleaved-caspase-3, as well as the ratio of Bcl-2-associated X protein (Bax) to B-cell lymphoma 2 (Bcl-2). Interestingly, except for KLE cells, hinokitiol induced autophagy by promoting the accumulation of the microtubule-associated protein light chain 3B (LC3B) and reducing the sequestosome-1 (p62/SQSTM1) protein level. Furthermore, hinokitiol triggered ROS production and upregulated the phosphorylation of extracellular-signal-regulated kinase (p-ERK1/2) in EC cells. These results demonstrate that hinokitiol has potential anti-proliferative and pro-apoptotic benefits in the treatment of endometrial cancer cell lines (Ishikawa, HEC-1A, and KLE). MDPI 2021-07-31 /pmc/articles/PMC8348875/ /pubmed/34361036 http://dx.doi.org/10.3390/ijms22158268 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chen, Hsin-Yuan
Cheng, Wen-Pin
Chiang, Yi-Fen
Hong, Yong-Han
Ali, Mohamed
Huang, Tsui-Chin
Wang, Kai-Lee
Shieh, Tzong-Ming
Chang, Hsin-Yi
Hsia, Shih-Min
Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE)
title Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE)
title_full Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE)
title_fullStr Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE)
title_full_unstemmed Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE)
title_short Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE)
title_sort hinokitiol exhibits antitumor properties through induction of ros-mediated apoptosis and p53-driven cell-cycle arrest in endometrial cancer cell lines (ishikawa, hec-1a, kle)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348875/
https://www.ncbi.nlm.nih.gov/pubmed/34361036
http://dx.doi.org/10.3390/ijms22158268
work_keys_str_mv AT chenhsinyuan hinokitiolexhibitsantitumorpropertiesthroughinductionofrosmediatedapoptosisandp53drivencellcyclearrestinendometrialcancercelllinesishikawahec1akle
AT chengwenpin hinokitiolexhibitsantitumorpropertiesthroughinductionofrosmediatedapoptosisandp53drivencellcyclearrestinendometrialcancercelllinesishikawahec1akle
AT chiangyifen hinokitiolexhibitsantitumorpropertiesthroughinductionofrosmediatedapoptosisandp53drivencellcyclearrestinendometrialcancercelllinesishikawahec1akle
AT hongyonghan hinokitiolexhibitsantitumorpropertiesthroughinductionofrosmediatedapoptosisandp53drivencellcyclearrestinendometrialcancercelllinesishikawahec1akle
AT alimohamed hinokitiolexhibitsantitumorpropertiesthroughinductionofrosmediatedapoptosisandp53drivencellcyclearrestinendometrialcancercelllinesishikawahec1akle
AT huangtsuichin hinokitiolexhibitsantitumorpropertiesthroughinductionofrosmediatedapoptosisandp53drivencellcyclearrestinendometrialcancercelllinesishikawahec1akle
AT wangkailee hinokitiolexhibitsantitumorpropertiesthroughinductionofrosmediatedapoptosisandp53drivencellcyclearrestinendometrialcancercelllinesishikawahec1akle
AT shiehtzongming hinokitiolexhibitsantitumorpropertiesthroughinductionofrosmediatedapoptosisandp53drivencellcyclearrestinendometrialcancercelllinesishikawahec1akle
AT changhsinyi hinokitiolexhibitsantitumorpropertiesthroughinductionofrosmediatedapoptosisandp53drivencellcyclearrestinendometrialcancercelllinesishikawahec1akle
AT hsiashihmin hinokitiolexhibitsantitumorpropertiesthroughinductionofrosmediatedapoptosisandp53drivencellcyclearrestinendometrialcancercelllinesishikawahec1akle